Skip to search formSkip to main contentSkip to account menu

MG 624

Known as: MG-624, MG624 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Potent Antiglioblastoma Agents by Hybridizing the Onium-Alkyloxy-Stilbene Based Structures of an α7-nAChR, α9-nAChR Antagonist and of a Pro-Oxidant Mitocan.
Adenocarcinoma and glioblastoma cell lines express α7- and α9α10-containing nicotinic acetylcholine receptors (nAChRs), whose… 
2012
2012
Erratum to: MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway
There was an error in the section entitled ‘‘Antitumor studies in nude mice’’ on page 104. The control group of H69 tumor-bearing… 
2010
2010
MG624, an α7‐nicotinic receptor antagonist inhibits growth of human small cell lung cancer by induction of p73
Small cell lung cancer (SCLC) is characterized by rapid progression, early metastasis and low survival rates. Smoking has been… 
2009
2009
T1220 Pharmacologic Specificity of Nicotinic Receptors Mediating Relaxation of Muscarinic Receptor Pre-Contracted Human and Pig Gastric Clasp Fibers
2009
2009
T1221 Speech Therapy in Patients with Excessive Supragastric Belching
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)